Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20


The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells.

Ogara MF, Rodríguez-Seguí SA, Marini M, Nacht AS, Stortz M, Levi V, Presman DM, Vicent GP, Pecci A.

Nucleic Acids Res. 2019 Nov 18;47(20):10645-10661. doi: 10.1093/nar/gkz857.


C/EBPα mediates the growth inhibitory effect of progestins on breast cancer cells.

Nacht AS, Ferrari R, Zaurin R, Scabia V, Carbonell-Caballero J, Le Dily F, Quilez J, Leopoldi A, Brisken C, Beato M, Vicent GP.

EMBO J. 2019 Sep 16;38(18):e101426. doi: 10.15252/embj.2018101426. Epub 2019 Aug 2.


Hormone-control regions mediate steroid receptor-dependent genome organization.

Le Dily F, Vidal E, Cuartero Y, Quilez J, Nacht AS, Vicent GP, Carbonell-Caballero J, Sharma P, Villanueva-Cañas JL, Ferrari R, De Llobet LI, Verde G, Wright RHG, Beato M.

Genome Res. 2019 Jan;29(1):29-39. doi: 10.1101/gr.243824.118. Epub 2018 Dec 14.


Steroid hormone receptors silence genes by a chromatin-targeted mechanism similar to those used for gene activation.

Nacht AS, Beato M, Vicent GP.

Transcription. 2017 Jan;8(1):15-20. doi: 10.1080/21541264.2016.1242456. Epub 2016 Oct 4.


Hormone-induced repression of genes requires BRG1-mediated H1.2 deposition at target promoters.

Nacht AS, Pohl A, Zaurin R, Soronellas D, Quilez J, Sharma P, Wright RH, Beato M, Vicent GP.

EMBO J. 2016 Aug 15;35(16):1822-43. doi: 10.15252/embj.201593260. Epub 2016 Jul 7.


ADP-ribose-derived nuclear ATP synthesis by NUDIX5 is required for chromatin remodeling.

Wright RH, Lioutas A, Le Dily F, Soronellas D, Pohl A, Bonet J, Nacht AS, Samino S, Font-Mateu J, Vicent GP, Wierer M, Trabado MA, Schelhorn C, Carolis C, Macias MJ, Yanes O, Oliva B, Beato M.

Science. 2016 Jun 3;352(6290):1221-5. doi: 10.1126/science.aad9335.


Pilot Study of Physiologic Partograph Use Among Low-Risk, Nulliparous Women With Spontaneous Labor Onset.

Neal JL, Lowe NK, Nacht AS, Koschoreck K, Anderson J.

J Midwifery Womens Health. 2016 Mar-Apr;61(2):235-41. doi: 10.1111/jmwh.12442. Epub 2016 Feb 24.


Progesterone receptor interaction with chromatin.

Vicent GP, Nacht AS, Ballaré C, Zaurin R, Soronellas D, Beato M.

Methods Mol Biol. 2014;1204:1-14. doi: 10.1007/978-1-4939-1346-6_1.


The transcription factor GATA6 enables self-renewal of colon adenoma stem cells by repressing BMP gene expression.

Whissell G, Montagni E, Martinelli P, Hernando-Momblona X, Sevillano M, Jung P, Cortina C, Calon A, Abuli A, Castells A, Castellvi-Bel S, Nacht AS, Sancho E, Stephan-Otto Attolini C, Vicent GP, Real FX, Batlle E.

Nat Cell Biol. 2014 Jul;16(7):695-707. doi: 10.1038/ncb2992. Epub 2014 Jun 22.


Unliganded progesterone receptor-mediated targeting of an RNA-containing repressive complex silences a subset of hormone-inducible genes.

Vicent GP, Nacht AS, Zaurin R, Font-Mateu J, Soronellas D, Le Dily F, Reyes D, Beato M.

Genes Dev. 2013 May 15;27(10):1179-97. doi: 10.1101/gad.215293.113.


Progesterone receptor induces bcl-x expression through intragenic binding sites favoring RNA polymerase II elongation.

Bertucci PY, Nacht AS, Alló M, Rocha-Viegas L, Ballaré C, Soronellas D, Castellano G, Zaurin R, Kornblihtt AR, Beato M, Vicent GP, Pecci A.

Nucleic Acids Res. 2013 Jul;41(12):6072-86. doi: 10.1093/nar/gkt327. Epub 2013 May 2.


CDK2-dependent activation of PARP-1 is required for hormonal gene regulation in breast cancer cells.

Wright RH, Castellano G, Bonet J, Le Dily F, Font-Mateu J, Ballaré C, Nacht AS, Soronellas D, Oliva B, Beato M.

Genes Dev. 2012 Sep 1;26(17):1972-83. doi: 10.1101/gad.193193.112.


Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation.

Vicent GP, Nacht AS, Font-Mateu J, Castellano G, Gaveglia L, Ballaré C, Beato M.

Genes Dev. 2011 Apr 15;25(8):845-62. doi: 10.1101/gad.621811. Epub 2011 Mar 29.


Minireview: role of kinases and chromatin remodeling in progesterone signaling to chromatin.

Vicent GP, Nacht AS, Zaurín R, Ballaré C, Clausell J, Beato M.

Mol Endocrinol. 2010 Nov;24(11):2088-98. doi: 10.1210/me.2010-0027. Epub 2010 May 19. Review.


Erk signaling and chromatin remodeling in MMTV promoter activation by progestins.

Vicent GP, Zaurin R, Ballaré C, Nacht AS, Beato M.

Nucl Recept Signal. 2009 Oct 2;7:e008. doi: 10.1621/nrs.07008. Review.


Nuclear factor 1 synergizes with progesterone receptor on the mouse mammary tumor virus promoter wrapped around a histone H3/H4 tetramer by facilitating access to the central hormone-responsive elements.

Vicent GP, Zaurin R, Nacht AS, Font-Mateu J, Le Dily F, Beato M.

J Biol Chem. 2010 Jan 22;285(4):2622-31. doi: 10.1074/jbc.M109.060848. Epub 2009 Nov 24.


Two chromatin remodeling activities cooperate during activation of hormone responsive promoters.

Vicent GP, Zaurin R, Nacht AS, Li A, Font-Mateu J, Le Dily F, Vermeulen M, Mann M, Beato M.

PLoS Genet. 2009 Jul;5(7):e1000567. doi: 10.1371/journal.pgen.1000567. Epub 2009 Jul 17.


Convergence on chromatin of non-genomic and genomic pathways of hormone signaling.

Vicent GP, Ballaré C, Nacht AS, Clausell J, Subtil-Rodríguez A, Quiles I, Jordan A, Beato M.

J Steroid Biochem Mol Biol. 2008 Apr;109(3-5):344-9. doi: 10.1016/j.jsbmb.2008.03.015. Epub 2008 Mar 13.


Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3.

Vicent GP, Ballaré C, Nacht AS, Clausell J, Subtil-Rodríguez A, Quiles I, Jordan A, Beato M.

Mol Cell. 2006 Nov 3;24(3):367-81.


DNA instructed displacement of histones H2A and H2B at an inducible promoter.

Vicent GP, Nacht AS, Smith CL, Peterson CL, Dimitrov S, Beato M.

Mol Cell. 2004 Nov 5;16(3):439-52.

Supplemental Content

Loading ...
Support Center